Skip to main content
Clinical Trials/CTRI/2023/10/058517
CTRI/2023/10/058517
Recruiting
未知

Development and Evaluation of a Multimodal Protocol for Pulmonary and Physical Function among Postmenopausal Women - NI

Chhatrapati Shahu Ji Maharaj University0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Chhatrapati Shahu Ji Maharaj University
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Chhatrapati Shahu Ji Maharaj University

Eligibility Criteria

Inclusion Criteria

  • The participants will be included if they will be
  • Women aged 40 to 55 years will be recruited and depending on the menstrual history participants will be classified as premenopausal and postmenopausal. Menstrual bleeding pattern will be classified based on series of questions.
  • Asymptomatic women with stable vitals
  • Body mass index of 18\-5 to 29\.9 kg/m2
  • Absence of any acute disease in the 6 weeks preceding the study.
  • Second Part
  • Development of multimodal protocol and its pilot testing
  • The sample population will include postmenopausal women.
  • The sample size and selection criteria will depend on preliminary findings.
  • The sample population will include postmenopausal women.

Exclusion Criteria

  • Any documented health problem or use of medication that might interfere with the ability to perform physical exercises (such as impaired cognition, and metabolic, cardiac, neuromuscular or musculoskeletal disease).
  • Use of walking aids
  • Resting blood pressure \>139/89 mmHg,
  • Resting heart rate (HR) ?100 beats per min.
  • Peri\-menopausal women with or without use of hormone
  • Second Part
  • Development of multimodal protocol and its pilot testing
  • The sample size and selection criteria will depend on preliminary findings.
  • The sample size and selection criteria will depend on results of phase 1\.

Outcomes

Primary Outcomes

Not specified

Similar Trials